Reuters logo
BRIEF-Biomed recognises impairments for FY 2016
April 14, 2017 / 6:24 AM / 7 months ago

BRIEF-Biomed recognises impairments for FY 2016

April 14 (Reuters) - Biomed Lublin Wytwornia Surowic i Szczepionek SA (Biomed):

* Said on Thursday that it recognised impairments for FY 2016

* The company made impairments on stock value of finished goods for 8.9 million zlotys ($2.22 million) and stock value of production in progress for 210,224 zlotys

* The company made also impairments on value of receivables from deliveries and services for 493,103 zlotys and value of property in Mielec for 6.8 million zlotys

* The company has also isolated the real estates which it do not use and plans to sell and valued it at fair value

* Real estates have been counted as investment, their carrying value increased by 5.7 million zlotys what impacts positively on FY 2016 results

Source text for Eikon:

Further company coverage: ($1 = 4.0014 zlotys) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below